Intravenous immunoglobulin (IVIG) in children

Intravenous immunoglobulin (IVIG) as an alternative to plasma proteins (IgG), In patients with low or Immunodeficiency prescribed. Enough IVIG recommended to patients with immune deficiency Immunoglobulins in order to maintain levels of antibody to prevent infection and provide a passive safety. The purpose of this paper is to acquaint the use of Intravenous immunoglobulin in different conditions in children.

This study provides an overview of library resources and databases (Pub med, Medline, Google, Sid, Magiran, …) with the literature review from 2010 to 2014 with keywords (Children, Immunocompromised, Intravenous immunoglobulin) has been developed.

In recent years, intravenous immunoglobulin in the treatment of children as Hematologic disorders such as idiopathic thrombocytopenic purpura, autoimmune deficiency of Factor VIII, red cell aplasia associated with Parvovirus nephropathy immunoglobulin A, membranous glomerulonephritis, lupus, juvenile rheumatoid arthritis and Gillian Barre is used. It often appears during injection and setting the speed and amount of injection can be controlled. Headache is the most common complication. Chills, dizziness, fever, itching, are possible side effects of this drug.

Overall immunoglobulin therapy is a tolerable intravenous in pediatric patients with antibody deficiency However, all patients receiving IVIG in the treatment of symptoms should be monitored, risks, side effects of IVIG, management and use of IVIG familiar place.